These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18783305)

  • 61. Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer.
    Lønning PE; Geisler J; Krag LE; Erikstein B; Bremnes Y; Hagen AI; Schlichting E; Lien EA; Ofjord ES; Paolini J; Polli A; Massimini G
    J Clin Oncol; 2005 Aug; 23(22):5126-37. PubMed ID: 15983390
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Exemestane in breast cancer: current status and future directions.
    Lønning PE
    Clin Breast Cancer; 2000 Sep; 1 Suppl 1():S28-33. PubMed ID: 11970747
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Treatment with levothyroxin in subclinical hypothyroidism is associated with increased mortality in the elderly.
    Grossman A; Feldhamer I; Meyerovitch J
    Eur J Intern Med; 2018 Apr; 50():65-68. PubMed ID: 29174213
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of thyroid hormone replacement on methionine-stimulated homocysteine levels in patients with subclinical hypothyroidism: a randomized, double-blind, placebo-controlled study.
    Meek S; Smallridge RC
    Endocr Pract; 2006; 12(5):529-34. PubMed ID: 17002927
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment of Subclinical Hypothyroidism or Hypothyroxinemia in Pregnancy.
    Casey BM; Thom EA; Peaceman AM; Varner MW; Sorokin Y; Hirtz DG; Reddy UM; Wapner RJ; Thorp JM; Saade G; Tita AT; Rouse DJ; Sibai B; Iams JD; Mercer BM; Tolosa J; Caritis SN; VanDorsten JP;
    N Engl J Med; 2017 Mar; 376(9):815-825. PubMed ID: 28249134
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Undertreated hypothyroidism due to calcium or iron supplementation corrected by oral liquid levothyroxine.
    Benvenga S; Di Bari F; Vita R
    Endocrine; 2017 Apr; 56(1):138-145. PubMed ID: 28155174
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Serum TSH concentration as an aid to monitoring compliance with thyroid hormone therapy in hypothyroidism.
    England ML; Hershman JM
    Am J Med Sci; 1986 Nov; 292(5):264-6. PubMed ID: 3777010
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues.
    Staub JJ; Althaus BU; Engler H; Ryff AS; Trabucco P; Marquardt K; Burckhardt D; Girard J; Weintraub BD
    Am J Med; 1992 Jun; 92(6):631-42. PubMed ID: 1605145
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Pseudomalabsorption of levothyroxine: a case report].
    Pedrosa W; Santana G
    Arq Bras Endocrinol Metabol; 2005 Apr; 49(2):308-13. PubMed ID: 16184262
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Subclinical hypothyroidism in childhood, treatment or only follow-up?
    Murillo-Vallés M; Martinez S; Aguilar-Riera C; Garcia-Martin MA; Bel-Comós J; Ybern MLG
    BMC Pediatr; 2020 Jun; 20(1):282. PubMed ID: 32505175
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Diagnosis and management of subclinical hypothyroidism in pregnancy.
    Negro R; Stagnaro-Green A
    BMJ; 2014 Oct; 349():g4929. PubMed ID: 25288580
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MRI-demonstrable regression of a pituitary mass in a case of primary hypothyroidism after a week of acute thyroid hormone therapy.
    Sarlis NJ; Brucker-Davis F; Doppman JL; Skarulis MC
    J Clin Endocrinol Metab; 1997 Mar; 82(3):808-11. PubMed ID: 9062487
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women.
    Jahanzeb M
    Clin Ther; 2007 Aug; 29(8):1535-47. PubMed ID: 17919537
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Subclinical hypothyroidism].
    Krysiak R; Marek B; Okopień B
    Wiad Lek; 2008; 61(4-6):139-45. PubMed ID: 18939365
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Subclinical hypothyroidism presenting with gait abnormality.
    Edvardsson B; Persson S
    Neurologist; 2010 Mar; 16(2):115-6. PubMed ID: 20220447
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Falsely raised TSH levels due to human anti-mouse antibody interfering with thyrotropin assay.
    Santhana Krishnan SG; Pathalapati R; Kaplan L; Cobbs RK
    Postgrad Med J; 2006 Nov; 82(973):e27. PubMed ID: 17099084
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Normal thyroxine and elevated thyrotropin concentrations: evolving hypothyroidism or persistent euthyroidism with reset thyrostat.
    Kabadi UM; Cech R
    J Endocrinol Invest; 1997 Jun; 20(6):319-26. PubMed ID: 9294777
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Subclinical Hypothyroidism on the Elderly].
    Macedo Silva S; Carvalho A; Lopes-Pereira M; Fernandes V
    Acta Med Port; 2018 Dec; 31(12):766-773. PubMed ID: 30684374
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Exemestane in advanced breast cancer.
    Buzdar A
    Anticancer Drugs; 2000 Sep; 11(8):609-16. PubMed ID: 11081451
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Regorafenib-induced hypothyroidism and cancer-related fatigue: is there a potential link?
    Pani F; Massidda M; Pusceddu V; Puzzoni M; Massa E; Madeddu C; Scartozzi M; Mariotti S
    Eur J Endocrinol; 2017 Jul; 177(1):85-92. PubMed ID: 28468766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.